OTCPK:DCPXF (Denmark)
Â
Unit (5 Ordinary shares & 2 Wrts)
$
0.01
0 (0%)
10:10 PM EST
Business Description
DanCann Pharma AS
ISIN : DK0061410487
Share Class Description:
DCPXF: Unit (5 Ordinary shares & 2 Wrts)Compare
Compare
Traded in other countries / regions
DANCAN.SwedenDAN.GermanyDCPXF.USA IPO Date
2022-11-18Description
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -10.3 | |||||
Beneish M-Score | -17.11 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 54.6 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 70.4 | |||||
3-Year Book Growth Rate | -79.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.4 | |||||
Quick Ratio | 0.4 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 7.68 | |||||
Days Sales Outstanding | 72.62 | |||||
Days Payable | 54.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -187.7 | |||||
Shareholder Yield % | 20.05 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -50.88 | |||||
Operating Margin % | -249.07 | |||||
Net Margin % | -975.22 | |||||
FCF Margin % | -335.77 | |||||
ROE % | -126.05 | |||||
ROA % | -106.55 | |||||
ROIC % | -27.67 | |||||
ROC (Joel Greenblatt) % | -729.74 | |||||
ROCE % | -119.98 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.3 | |||||
PB Ratio | 0.36 | |||||
EV-to-EBIT | -0.2 | |||||
EV-to-EBITDA | -0.96 | |||||
EV-to-Revenue | 1.89 | |||||
EV-to-FCF | -0.56 | |||||
Earnings Yield (Greenblatt) % | -500 | |||||
FCF Yield % | -263.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DCPXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DanCann Pharma AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.931 | ||
EPS (TTM) ($) | -0.021 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0.01 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.01 - 0.01 | ||
Shares Outstanding (Mil) | 1,206.1 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DanCann Pharma AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DanCann Pharma AS Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
DanCann Pharma AS Frequently Asked Questions
What is DanCann Pharma AS(DCPXF)'s stock price today?
The current price of DCPXF is $0.01. The 52 week high of DCPXF is $0.01 and 52 week low is $0.01.
When is next earnings date of DanCann Pharma AS(DCPXF)?
The next earnings date of DanCann Pharma AS(DCPXF) is 2024-08-30.
Does DanCann Pharma AS(DCPXF) pay dividends? If so, how much?
DanCann Pharma AS(DCPXF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |